Back
Guidewire Software Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
45
GWRE
Guidewire Software
Last Price:
110.80
Seasonality Move:
7.76%
Buy
52
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
37.54
Seasonality Move:
-15.12%
Sell
45
Guidewire Software (GWRE)
is a Sell
Is Guidewire Software a Buy, Sell or Hold?
- The current Guidewire Software [GWRE] share price is $110.40. The Score for GWRE is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- GWRE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $37.03. The Score for CRBP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GWRE Stock Price Chart
What is Guidewire Software's stock price today?
-
The Guidewire Software share price today is $110.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GWRE is experiencing selling pressure, which indicates risk of future bearish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $37.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
GWRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.71 | Sell |
Relative Strength Index (14 RSI): | 43.64 | Sell |
Chaikin Money Flow: | -647048 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.03 - 115.61) | Sell |
Bollinger Bands (100): | (106.36 - 117.64) | Sell |
CRBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.31 | Sell |
Relative Strength Index (14 RSI): | 49.95 | Sell |
Chaikin Money Flow: | 138813 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.78 - 40.1) | Sell |
Bollinger Bands (100): | (10.05 - 38.69) | Buy |
GWRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.69 | Sell |
20-day SMA: | 112.04 | Sell |
50-day SMA: | 114.53 | Sell |
200-day SMA: | 100.11 | Buy |
8-day EMA: | 111.74 | Sell |
20-day EMA: | 112.15 | Sell |
50-day EMA: | 112.79 | Sell |
200-day EMA: | 102.2 | Buy |
CRBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.31 | Buy |
20-day SMA: | 38.11 | Sell |
50-day SMA: | 36.79 | Buy |
200-day SMA: | 15.23 | Buy |
8-day EMA: | 36.34 | Buy |
20-day EMA: | 37.22 | Sell |
50-day EMA: | 34.42 | Buy |
200-day EMA: | 20.11 | Buy |
Guidewire Software Earnings Growth & GWRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.14 per share, an increase this year of $1.15 per share, and an increase next year of $0.59 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.66 per share, and an increase next year of $0.09 per share.
Guidewire Software Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corbus Pharmaceuticals Holdings Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |